Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM)
₹ 2612.55 -80.35 (-2.98%) Market Cap: 884.21 Bil Enterprise Value: 912.62 Bil PE Ratio: 59.16 PB Ratio: 13.18 GF Score: 96/100

Q2 2021 Torrent Pharmaceuticals Ltd Earnings Call Transcript

Oct 26, 2020 / 12:00PM GMT
Release Date Price: ₹1328.33 (-2.82%)
Operator

Ladies and gentlemen, good day, and welcome to Torrent Pharmaceuticals Limited Q2 FY 2021 Earnings Conference Call.

We have with us today Mr. Sanjay Gupta, Executive Director, International Business; Mr. Sudhir Menon, Executive Director, Finance and Chief Financial Officer; and Mr. Aman Mehta, Chief Marketing Officer, India Business. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Sanjay Gupta. Thank you, and over to you, sir.

Sanjay Gupta
Torrent Pharmaceuticals Limited - Executive Director of International Business

Thank you. Good evening, everybody. Welcome to our Q2 FY '21 earnings call. I would like to begin by commenting on current market trends. We are seeing a strong recovery in our branded generic markets. In India, the field activities are back to 70% to 80% of normal levels. With doctors spending higher in-clinic time due to increase in patient footfall, Q2 IPM growth recovered to positive 1% from negative 6% in Q1. We continue to see strong growth in the chronic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot